FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Forshay Steven E 2. Date of Event Requiring Statement (Month/Day/Year) 02/03/2015 3. Issuer Name and Ticker or Trading Symbol Dolby Laboratories, Inc. [DLB] (Last) (First) (Middle) C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP, Advanced Technology Group 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) SAN FRANCISCO, CA 94103 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Class A Common Stock 45,386.826 (1) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	  (2)	06/16/2015	Class A Common Stock	44,548	$ 17.24	D	Â
Employee Stock Option (Right to Buy)	  (3)	11/14/2016	Class A Common Stock	38,979	$ 25.26	D	Â
Employee Stock Option (Right to Buy)	  (4)	02/09/2019	Class A Common Stock	9,355	$ 28.9	D	Â
Employee Stock Option (Right to Buy)	  (5)	12/15/2021	Class A Common Stock	30,069	$ 28.24	D	Â
Employee Stock Option (Right to Buy)	  (6)	12/21/2022	Class A Common Stock	24,000	$ 30.49	D	Â
Employee Stock Option (Right to Buy)	  (7)	12/16/2023	Class A Common Stock	29,400	$ 37.35	D	Â
Employee Stock Option (Right to Buy)	  (8)	12/15/2024	Class A Common Stock	36,000	$ 42.98	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Forshay Steven E C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO, CA 94103	Â	Â	  SVP, Advanced Technology Group	Â

Signatures

/s/ Daniel Rodriguez, Attorney-in-Fact for Steven Forshay		12/17/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Shares held include 18,893 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
(2)	This option became exercisable in four equal annual installments beginning on June 16, 2006 and vesting on each anniversary thereof.
(3)	This option became exercisable in four equal annual installments beginning on November 14, 2007 and vesting on each anniversary thereof.
(4)	1/4 of the total number of shares issuable under this option vested on the first anniversary of February 9, 2009 and the balance of the shares vested in equal monthly installments over the next 36 months.
(5)	1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2011 and the balance of the shares vest in equal monthly installments over the next 36 months.
(6)	1/4 of the total number of shares issuable under this option vested on the first anniversary of December 21, 2012 and the balance of the shares vest in equal monthly installments over the next 36 months.
(7)	1/4 of the total number of shares issuable under this option vested on the first anniversary of December 16, 2013 and the balance of the shares vest in equal monthly installments over the next 36 months.
(8)	1/4 of the total number of shares issuable under this option vests on the first anniversary of December 15, 2014 and the balance of the shares vest in equal monthly installments over the next 36 months.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.